References
- Cantor DI, Nice EC, Baker MS. Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment. Expert Rev Proteomics. 2015;12:279–293.
- Addie RD, Balluff B, Bovée JV, et al. Current state and future challenges of mass spectrometry imaging for clinical research. Anal Chem. 2015;87:6426–6433.
- Liu F, Heck AJ. Interrogating the architecture of protein assemblies and protein interaction networks by cross-linking mass spectrometry. Curr Opin Struct Biol. 2015;35:100–108.
- Giesen C, Wang HA, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014;11:417–422.
- Durbin KR, Fornelli L, Fellers RT, et al. Quantitation and identification of thousands of human proteoforms below 30 kDa. J Proteome Res. 2016 Feb 11. [Epub ahead of print] Jan 22.
- Omenn GS, Lane L, Lundberg EK, et al. Metrics for the human proteome project 2015: progress on the human proteome and guidelines for high-confidence protein identification. J Proteome Res. 2015;14:3452–3460.
- Horvatovich P, Lundberg EK, Chen YJ, et al. Quest for missing proteins: update 2015 on chromosome-centric human proteome project. J Proteome Res. 2015;14:3415–3431.
- Hakhverdyan Z, Domanski M, Hough LE, et al. Rapid, optimized interactomic screening. Nat Methods. 2015;12:553–560.
- https://en.wikipedia.org/wiki/Huangdi_Neijing
- Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8:184–187.
- Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;9:491–496.
- Schork NJ. Personalized medicine: time for one-person trials. Nature. 2015;520:609–611.
- Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293–1307.
- Stanberry L, Mias GI, Haynes W, et al. Integrative analysis of longitudinal metabolomics data from a personal multi-omics profile. Metabolites. 2013;3:741–760.
- Andreu-Perez J, Poon CC, Merrifield RD, et al. Big Data for health. IEEE J Biomed Health Inform. 2015;19:1193–1208.
- Martin SF, Falkenberg H, Dyrlund TF, et al. PROTEIN CHALLENGE: crowd sourcing in proteomics analysis and software development. J Proteomics. 2013;88:41–46.
- Mittelstadt BD, Floridi L. The ethics of Big Data: current and foreseeable issues in biomedical contexts. Sci Eng Ethics. 2015 May 23. [Epub ahead of print].
- Poste G. Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. Trends Mol Med. 2012;18:717–722.
- Personalized Medicine Coalition. 2015 Progress report: personalized medicine at FDA [Internet]. [cited 2016 Mar 9]. http://www.personalizedmedicinecoalition.org/Userfiles/PMCCorporate/file/2015_Progress_Report_PM_at_FDA1.pdf